---
title: Pre-approval Information Exchange (PIE): Clarifying Legislation Creates Opportunities to Accelerate Product Launches
description: Learn how updated FDA guidance on Pre-Approval Information Exchange (PIE) empowers life sciences teams to engage providers earlier and more effectively.
image: https://blog.pocp.com/hubfs/20250331_1012_Data%20Pie%20Icon_simple_compose_01jqp8r4kxejqvfx8wdvkr3may.png
---
[](https://www.pocp.com/)
# Accelerating client's success
# using Health IT and
# business process solutions...
[Learn More](https://www.pocp.com/the-pocp-story/)
# Simplifying
# regulatory
## compliance...
[Learn More](https://www.pocp.com/regulatory-resource-center/)
# Creating value in today's
# healthcare ecosystem...
[Learn More](https://www.pocp.com/our-client/)
- Consulting
- [Strategy & Market Intelligence](https://www.pocp.com/strategy-market-intelligence/)
- [Education & Research](https://www.pocp.com/education-research/)
- [Value-Based Care Interoperability Roadmap](https://info.pocp.com/en-us/value-based-care-interoperability-strategy-and-roadmap)
- [Multi-stakeholder Collaboratives, Program Design and Management](https://www.pocp.com/multi-stakeholder-initiatives_program-design_management)
- [EHR Training Programs](https://www.pocp.com/ehr-training-programs/)
- [Life Sciences](https://www.pocp.com/life-sciences)
- [Regulatory Resource Center](https://www.pocp.com/regulatory-resource-center)
- About Us
- [The POCP Story](https://www.pocp.com/the-pocp-story/)
- [Our Clients](https://www.pocp.com/our-client/)
- [Health & IT Vendors](https://www.pocp.com/our-client/health-it-vendors/)
- [Payers & PBMS](https://www.pocp.com/our-client/payers-pbms/)
- [Accountable Care](https://www.pocp.com/our-client/accountable-care/)
- [Health Information Exchange](https://www.pocp.com/resource-library/health-information-exchange/)
- [Our Team](https://www.pocp.com/our-team/)
- [Government Contracting](https://info.pocp.com/gsa)
- [Press](https://www.pocp.com/press/)
- [Calendar](https://info.pocp.com/en-us/events)
- [Careers at POCP](https://www.pocp.com/the-pocp-story/careers-at-pocp/)
- Insights
- [Articles and Industry Comments](https://www.pocp.com/articles/)
- [Blog](https://blog.pocp.com/blog/)
- [Newsletters HIT Perspectives](https://www.pocp.com/insight/newsletters-2/)
- [Newsletters Biopharma](https://www.pocp.com/newsletters-biopharma/)
- [POCP Industry Reports](https://www.pocp.com/industry-reports)
- [POCP Industry Reports](https://www.pocp.com/industry-reports)
- [ePrior Authorization’s Real Benefits: Reducing Frictional Costs and Speeding Time to Therapy](https://www.pocp.com/downloads/ePAReport)
- [Real-Time Pharmacy Benefit Check Report](https://www.pocp.com/pocp-industry-reports/real-time-pharmacy-benefit-check-report/)
- [Fighting the Opioid Epidemic at the State- and Rx-Level Report](https://www.pocp.com/downloads/fighting-opioid-epidemic-at-rx-level-report)
- [ePrescribing State Law On-Demand](https://www.pocp.com/downloads/eprescribing-state-law-on-demand/)
- [State Law Review](https://www.pocp.com/statelawreview/)
- [Navigator](https://www.pocp.com/navigator/)
- [Podcasts](https://info.pocp.com/en-us/the-dish-on-health-it-podcast)
- [Presentations and Webinars](https://www.pocp.com/presentations/)
- [Resource Library](https://www.pocp.com/resource-library/)
- [White Papers, Webinars and Case Studies](https://www.pocp.com/white-papers-webinars-and-case-studies-2/)
- [Our video channel](https://www.pocp.com/our-video-channel)
- [Contact](https://www.pocp.com/contact/)
- Consulting
- [Strategy & Market Intelligence](https://www.pocp.com/strategy-market-intelligence/)
- [Education & Research](https://www.pocp.com/education-research/)
- [Value-Based Care Interoperability Roadmap](https://info.pocp.com/en-us/value-based-care-interoperability-strategy-and-roadmap)
- [Multi-stakeholder Collaboratives, Program Design and Management](https://www.pocp.com/multi-stakeholder-initiatives_program-design_management)
- [EHR Training Programs](https://www.pocp.com/ehr-training-programs/)
- [Life Sciences](https://www.pocp.com/life-sciences)
- [Regulatory Resource Center](https://www.pocp.com/regulatory-resource-center)
- About Us
- [The POCP Story](https://www.pocp.com/the-pocp-story/)
- [Our Clients](https://www.pocp.com/our-client/)
- [Health & IT Vendors](https://www.pocp.com/our-client/health-it-vendors/)
- [Payers & PBMS](https://www.pocp.com/our-client/payers-pbms/)
- [Accountable Care](https://www.pocp.com/our-client/accountable-care/)
- [Health Information Exchange](https://www.pocp.com/resource-library/health-information-exchange/)
- [Our Team](https://www.pocp.com/our-team/)
- [Government Contracting](https://info.pocp.com/gsa)
- [Press](https://www.pocp.com/press/)
- [Calendar](https://info.pocp.com/en-us/events)
- [Careers at POCP](https://www.pocp.com/the-pocp-story/careers-at-pocp/)
- Insights
- [Articles and Industry Comments](https://www.pocp.com/articles/)
- [Blog](https://blog.pocp.com/blog/)
- [Newsletters HIT Perspectives](https://www.pocp.com/insight/newsletters-2/)
- [Newsletters Biopharma](https://www.pocp.com/newsletters-biopharma/)
- [POCP Industry Reports](https://www.pocp.com/industry-reports)
- [POCP Industry Reports](https://www.pocp.com/industry-reports)
- [ePrior Authorization’s Real Benefits: Reducing Frictional Costs and Speeding Time to Therapy](https://www.pocp.com/downloads/ePAReport)
- [Real-Time Pharmacy Benefit Check Report](https://www.pocp.com/pocp-industry-reports/real-time-pharmacy-benefit-check-report/)
- [Fighting the Opioid Epidemic at the State- and Rx-Level Report](https://www.pocp.com/downloads/fighting-opioid-epidemic-at-rx-level-report)
- [ePrescribing State Law On-Demand](https://www.pocp.com/downloads/eprescribing-state-law-on-demand/)
- [State Law Review](https://www.pocp.com/statelawreview/)
- [Navigator](https://www.pocp.com/navigator/)
- [Podcasts](https://info.pocp.com/en-us/the-dish-on-health-it-podcast)
- [Presentations and Webinars](https://www.pocp.com/presentations/)
- [Resource Library](https://www.pocp.com/resource-library/)
- [White Papers, Webinars and Case Studies](https://www.pocp.com/white-papers-webinars-and-case-studies-2/)
- [Our video channel](https://www.pocp.com/our-video-channel)
- [Contact](https://www.pocp.com/contact/)
# Insights: Brief Points of View
# POCP Blog
---
## Pre-approval Information Exchange (PIE): Clarifying Legislation Creates Opportunities to Accelerate Product Launches
- April 01, 2025
- By [Brian Bamberger](https://blog.pocp.com/blog/author/brian-bamberger)
- [0 Comment](https://blog.pocp.com/blog/pre-approval-information-exchange-pie-clarifying-legislation-creates-opportunities-to-accelerate-product-launches#comments-listing)
Share this story:
## Are You Maximizing PIE's Potential?
Pre-Approval Information Exchange (PIE) enables life sciences manufacturers to provide clinical, health economic, and other information to Health Care Decision Makers (HCDM) before FDA approval to help make formulary and patient access decisions.
Recent legislation and clarified FDA guidance on PIE eliminated long-standing ambiguity around what can and cannot be shared with payers and HCDMs. Now, with firmer regulatory guardrails in place, you can fully leverage the PIE process to bring valuable clinical and economic insights to the right stakeholders at the right time. We have successfully worked with companies to create EHR Readiness Tools that can be used to respond to questions from health systems about how to identify patients and requirements for new treatment protocols. These tools have been well received by health systems and help to continue discussions from initial pre-approval information exchange information through approval.
## The Shift: Clarity Unlocks Opportunity
With new legislation providing greater certainty around PIE customer engagements, there is no need for manufacturers to navigate a gray area. You now have explicit guidance on how to communicate with payers, integrated delivery networks (IDNs), and other decision-makers about new products and indications in advance of FDA approval. This is a crucial shift. Why? Because it allows you to:
- **Ensure payer readiness** – Giving market access teams the ability to proactively share pre-approval data means that when your product launches, reimbursement and coverage decisions are already well-informed.
- **Support providers with better insights** – By strategically sharing economic and clinical data early, you help equip providers with the evidence they need to understand patient utilization projections, make formulary decisions, and provide patients with access to innovative therapies.
- **Align internal teams** – With clearer regulatory boundaries, marketing, health economics (HECON), managed care, and market access teams can collaborate more effectively to craft compelling, compliant pre-approval information to assist health systems in preparing to implement a new treatment.
## Strengthening Your PIE Dossier: Beyond the Basics
The [Academy of Managed Care Pharmacy (AMCP) Format for Formulary Submissions](https://www.amcp.org/resource/amcp-format-formulary-submissions-guidance) is a widely accepted template for presenting products, clinical trials, health economics, and other supporting evidence to HCDMs. A critical component of PIE dossiers is guidance for providers on configuring EHR systems to support real-world implementation of a new treatment.
- **Identifying the right patient population** – Providers can use their EHRs to identify eligible patients who may benefit from the new treatment to make forecasts and budget impact models.
- **Setting up EHR and other digital health workflows** – Information and instructions needed to configure the EHR workflow to prescribe and administer a new treatment along with patient support programs and distribution networks
- **Tracking outcomes** – Using EHR-based mechanisms, to track and analyze data that informs future formulary decisions.
These strategic additions can make a significant impact on payer and provider readiness, making your pre-approval resources much more valuable and practical tools for planning when an approval does occur.
## Seizing the PIE Advantage for Health System Customers
The firms that get PIE right won’t just be compliant—they’ll gain a competitive edge. Instead of waiting until launch to begin market education, your team can use PIE to provide providers with the information they need to implement a new treatment. This includes the EHR information and instructions needed to streamline prescribing and provide patients access at FDA approval.
That’s where we come in. At POCP, our experts deeply understand the EHR and can help you develop an essential component of your pre-approval materials for EHR Readiness. Our broad market experience across technology vendors and providers makes us a valuable member of your PIE team.
## The Time to Act is Now
With clearer regulatory guidance in place, the window to fully capitalize on pre-approval EHR discussions is wide open—but only for those who take action. Are you ready to ensure your market access and payer engagement strategies are ahead of the curve?
Let POCP’s deeply knowledgeable team help you build the critical EHR pieces to support an upcoming launch, ensuring you not only meet compliance requirements, and address health system requests for information, but also speed adoption by assisting health systems to prepare for your launch in advance. [**Reach out today to start the conversation**](https://www.pocp.com/contact/)**.**
- Post Categories
- [EHR](https://blog.pocp.com/blog/tag/ehr)
- [Life Sciences](https://blog.pocp.com/blog/tag/life-sciences)
- [Pre-approval Information Exchange](https://blog.pocp.com/blog/tag/pre-approval-information-exchange)
- [Drug Launch](https://blog.pocp.com/blog/tag/drug-launch)
- [Drug Manufacturers](https://blog.pocp.com/blog/tag/drug-manufacturers)
# POCP Blog
---
Search
- There are no suggestions because the search field is empty.
### RECENT POSTS
### CATEGORIES
- [Interoperability (40)](https://blog.pocp.com/blog/tag/interoperability)
- [Health IT Policy (39)](https://blog.pocp.com/blog/tag/health-it-policy)
- [CMS (29)](https://blog.pocp.com/blog/tag/cms)
- [FHIR (25)](https://blog.pocp.com/blog/tag/fhir)
- [EHR (24)](https://blog.pocp.com/blog/tag/ehr)
- [Health IT Trends (20)](https://blog.pocp.com/blog/tag/health-it-trends)
- [ePrescribing (19)](https://blog.pocp.com/blog/tag/eprescribing)
- [Prior Authorization (17)](https://blog.pocp.com/blog/tag/prior-authorization)
- [Real-Time Benefit Check (15)](https://blog.pocp.com/blog/tag/real-time-benefit-check)
- [Real-Time Pharmacy Benefit Check (15)](https://blog.pocp.com/blog/tag/real-time-pharmacy-benefit-check)
- [Regulatory Trends (15)](https://blog.pocp.com/blog/tag/regulatory-trends)
- [APIs (14)](https://blog.pocp.com/blog/tag/apis)
- [Artificial Intelligence (13)](https://blog.pocp.com/blog/tag/artificial-intelligence)
- [Life Sciences (12)](https://blog.pocp.com/blog/tag/life-sciences)
- [electronic prior authorization (12)](https://blog.pocp.com/blog/tag/electronic-prior-authorization)
- [health IT (12)](https://blog.pocp.com/blog/tag/health-it)
- [NCPDP (10)](https://blog.pocp.com/blog/tag/ncpdp)
- [Policy (10)](https://blog.pocp.com/blog/tag/policy)
- [pharmacy interoperability (10)](https://blog.pocp.com/blog/tag/pharmacy-interoperability)
- [electronic health records (9)](https://blog.pocp.com/blog/tag/electronic-health-records)
- [ASTP (8)](https://blog.pocp.com/blog/tag/astp)
- [CMS NPRM (8)](https://blog.pocp.com/blog/tag/cms-nprm)
- [Payer (8)](https://blog.pocp.com/blog/tag/payer)
- [health information exchange (8)](https://blog.pocp.com/blog/tag/health-information-exchange)
- [HL7 (7)](https://blog.pocp.com/blog/tag/hl7)
- [Specialty Pharmacy (7)](https://blog.pocp.com/blog/tag/specialty-pharmacy)
- [Standards Development (7)](https://blog.pocp.com/blog/tag/standards-development)
- [TEFCA (7)](https://blog.pocp.com/blog/tag/tefca)
- [Value-Based Care (7)](https://blog.pocp.com/blog/tag/value-based-care)
- [e-Prescribing (7)](https://blog.pocp.com/blog/tag/e-prescribing)
- [electronic prescribing (7)](https://blog.pocp.com/blog/tag/electronic-prescribing)
- [Da Vinci Project (6)](https://blog.pocp.com/blog/tag/da-vinci-project)
- [Federal Healthcare Policy (6)](https://blog.pocp.com/blog/tag/federal-healthcare-policy)
- [HHS (6)](https://blog.pocp.com/blog/tag/hhs)
- [HTI-2 (6)](https://blog.pocp.com/blog/tag/hti-2)
- [ONC (6)](https://blog.pocp.com/blog/tag/onc)
- [Payer Interoperability (6)](https://blog.pocp.com/blog/tag/payer-interoperability)
- [Pharmacy (6)](https://blog.pocp.com/blog/tag/pharmacy)
- [Strategy and Research (6)](https://blog.pocp.com/blog/tag/strategy-and-research)
- [healthcare reform (6)](https://blog.pocp.com/blog/tag/healthcare-reform)
- [pharmaceutical marketing (6)](https://blog.pocp.com/blog/tag/pharmaceutical-marketing)
- [21st Century Cures Act (5)](https://blog.pocp.com/blog/tag/21st-century-cures-act)
- [Consent (5)](https://blog.pocp.com/blog/tag/consent)
- [EHR Usability (5)](https://blog.pocp.com/blog/tag/ehr-usability)
- [EPCS (5)](https://blog.pocp.com/blog/tag/epcs)
- [Health Plans (5)](https://blog.pocp.com/blog/tag/health-plans)
- [Health Technology Solutions (5)](https://blog.pocp.com/blog/tag/health-technology-solutions)
- [Information Blocking (5)](https://blog.pocp.com/blog/tag/information-blocking)
- [NCPDP SCRIPT (5)](https://blog.pocp.com/blog/tag/ncpdp-script)
- [Patient Data (5)](https://blog.pocp.com/blog/tag/patient-data)
- [Strategic roadmap (5)](https://blog.pocp.com/blog/tag/strategic-roadmap)
- [health equity (5)](https://blog.pocp.com/blog/tag/health-equity)
- [pharmacy advance practice (5)](https://blog.pocp.com/blog/tag/pharmacy-advance-practice)
- [population health (5)](https://blog.pocp.com/blog/tag/population-health)
- [Clinical Decision Support (4)](https://blog.pocp.com/blog/tag/cds)
- [Digital Health Programs (4)](https://blog.pocp.com/blog/tag/digital-health-programs)
- [Digital Therapeutics (4)](https://blog.pocp.com/blog/tag/digital-therapeutics)
- [EHR Dashboard (4)](https://blog.pocp.com/blog/tag/ehr-dashboard)
- [HIE (4)](https://blog.pocp.com/blog/tag/hie)
- [Healthcare AI (4)](https://blog.pocp.com/blog/tag/healthcare-ai)
- [Meaningful Use (4)](https://blog.pocp.com/blog/tag/meaningful-use)
- [PDMP (4)](https://blog.pocp.com/blog/tag/pdmp)
- [Pharmaceutical Manufacturers (4)](https://blog.pocp.com/blog/tag/pharmaceutical-manufacturers)
- [Pharmacy Benefit Management (4)](https://blog.pocp.com/blog/tag/pharmacy-benefit-management)
- [burden reduction (4)](https://blog.pocp.com/blog/tag/burden-reduction)
- [ePrior Authorization (4)](https://blog.pocp.com/blog/tag/eprior-authorization)
- [healthcare regulations (4)](https://blog.pocp.com/blog/tag/healthcare-regulations)
- [price transparency (4)](https://blog.pocp.com/blog/tag/price-transparency)
- [Administrative Burden (3)](https://blog.pocp.com/blog/tag/administrative-burden)
- [COVID-19 (3)](https://blog.pocp.com/blog/tag/covid-19)
- [Clinical Calculators (3)](https://blog.pocp.com/blog/tag/clinical-calculators)
- [Data Governance (3)](https://blog.pocp.com/blog/tag/data-governance)
- [Diabetes Care (3)](https://blog.pocp.com/blog/tag/diabetes-care)
- [Digital Health (3)](https://blog.pocp.com/blog/tag/digital-health)
- [Drug price transparency (3)](https://blog.pocp.com/blog/tag/drug-price-transparency)
- [EHR Guides (3)](https://blog.pocp.com/blog/tag/ehr-guides)
- [EHR Reports (3)](https://blog.pocp.com/blog/tag/ehr-reports)
- [EHRs (3)](https://blog.pocp.com/blog/tag/ehrs)
- [HIMSS (3)](https://blog.pocp.com/blog/tag/himss)
- [Implementation (3)](https://blog.pocp.com/blog/tag/implementation)
- [Innovation (3)](https://blog.pocp.com/blog/tag/innovation)
- [Medication Adherence (3)](https://blog.pocp.com/blog/tag/medication-adherence)
- [Medication Therapy Management (3)](https://blog.pocp.com/blog/tag/mtm)
- [National Patient Identifier (3)](https://blog.pocp.com/blog/tag/national-patient-identifier)
- [Patient Safety (3)](https://blog.pocp.com/blog/tag/patient-safety)
- [Pharmacy Benefit (3)](https://blog.pocp.com/blog/tag/pharmacy-benefit)
- [Policy monitoring (3)](https://blog.pocp.com/blog/tag/policy-monitoring)
- [Request for Information (3)](https://blog.pocp.com/blog/tag/request-for-information)
- [Speed to Therapy (3)](https://blog.pocp.com/blog/tag/speed-to-therapy)
- [patient access (3)](https://blog.pocp.com/blog/tag/patient-access)
- [pharmacist (3)](https://blog.pocp.com/blog/tag/pharmacist)
- [pharmacy business model (3)](https://blog.pocp.com/blog/tag/pharmacy-business-model)
- [state prescribing laws (3)](https://blog.pocp.com/blog/tag/state-prescribing-laws)
- [AI Policy (2)](https://blog.pocp.com/blog/tag/ai-policy)
- [CDC (2)](https://blog.pocp.com/blog/tag/cdc)
- [CMS-0062P (2)](https://blog.pocp.com/blog/tag/cms-0062p)
- [Centers for Disease Control (2)](https://blog.pocp.com/blog/tag/centers-for-disease-control)
- [Controlled Substances (2)](https://blog.pocp.com/blog/tag/controlled-substances)
- [Data Efficiency (2)](https://blog.pocp.com/blog/tag/data-efficiency)
- [EHR Certification (2)](https://blog.pocp.com/blog/tag/ehr-certification)
- [Epic (2)](https://blog.pocp.com/blog/tag/epic)
- [FDA (2)](https://blog.pocp.com/blog/tag/fda)
- [Formulary and Benefit (2)](https://blog.pocp.com/blog/tag/formulary-and-benefit)
- [H.R. 6 (2)](https://blog.pocp.com/blog/tag/h-r-6)
- [Market Assessment (2)](https://blog.pocp.com/blog/tag/market-assessment)
- [Medical Benefit (2)](https://blog.pocp.com/blog/tag/medical-benefit)
- [Medical Pharmacy Benefit Integration (2)](https://blog.pocp.com/blog/tag/medical-pharmacy-benefit-integration)
- [Medicare Payment Reform (2)](https://blog.pocp.com/blog/tag/medicare-payment-reform)
- [Member Data (2)](https://blog.pocp.com/blog/tag/member-data)
- [NCPDP Telecommunications Standard Version F6 (2)](https://blog.pocp.com/blog/tag/ncpdp-telecommunications-standard-version-f6)
- [ONC Physician Burden Reduction (2)](https://blog.pocp.com/blog/tag/onc-physician-burden-reduction)
- [Opioid prescribing laws (2)](https://blog.pocp.com/blog/tag/opioid-prescribing-laws)
- [PGx (2)](https://blog.pocp.com/blog/tag/pgx)
- [Part D (2)](https://blog.pocp.com/blog/tag/part-d)
- [Patient Record Sharing (2)](https://blog.pocp.com/blog/tag/patient-record-sharing)
- [Population Health Management (2)](https://blog.pocp.com/blog/tag/population-health-management)
- [Pre-approval Information Exchange (2)](https://blog.pocp.com/blog/tag/pre-approval-information-exchange)
- [Precision Medicine (2)](https://blog.pocp.com/blog/tag/precision-medicine)
- [Quality Reporting (2)](https://blog.pocp.com/blog/tag/quality-reporting)
- [REMS (2)](https://blog.pocp.com/blog/tag/rems)
- [Regulatory landscape (2)](https://blog.pocp.com/blog/tag/regulatory-landscape)
- [Specialty Pharmacy Automation (2)](https://blog.pocp.com/blog/tag/specialty-pharmacy-automation)
- [Specialty ePrescribing (2)](https://blog.pocp.com/blog/tag/specialty-eprescribing)
- [Speed to Medication Therapy (2)](https://blog.pocp.com/blog/tag/speed-to-medication-therapy)
- [State policy (2)](https://blog.pocp.com/blog/tag/state-policy)
- [Telehealth (2)](https://blog.pocp.com/blog/tag/telehealth)
- [Telemedicine (2)](https://blog.pocp.com/blog/tag/telemedicine)
- [care coordination (2)](https://blog.pocp.com/blog/tag/care-coordination)
- [care gaps (2)](https://blog.pocp.com/blog/tag/care-gaps)
- [community pharmacy (2)](https://blog.pocp.com/blog/tag/community-pharmacy)
- [compliance (2)](https://blog.pocp.com/blog/tag/compliance)
- [ePA (2)](https://blog.pocp.com/blog/tag/epa)
- [eRx (2)](https://blog.pocp.com/blog/tag/erx)
- [health dashboards (2)](https://blog.pocp.com/blog/tag/health-dashboards)
- [medication management (2)](https://blog.pocp.com/blog/tag/medication-management)
- [opioid abuse (2)](https://blog.pocp.com/blog/tag/opioid-abuse)
- [prior authorizations (2)](https://blog.pocp.com/blog/tag/prior-authorizations)
- [wearables (2)](https://blog.pocp.com/blog/tag/wearables)
- [ACO (1)](https://blog.pocp.com/blog/tag/aco)
- [AI in Healthcare (1)](https://blog.pocp.com/blog/tag/ai-in-healthcare)
- [Antikickback Statutes Reform (1)](https://blog.pocp.com/blog/tag/antikickback-statutes-reform)
- [Biologics and Biosimilars Naming (1)](https://blog.pocp.com/blog/tag/biologics-and-biosimilars-naming)
- [Biosimilars (1)](https://blog.pocp.com/blog/tag/biosimilars)
- [Business Process (1)](https://blog.pocp.com/blog/tag/business-process)
- [CAQH Phase V Operating Rules (1)](https://blog.pocp.com/blog/tag/caqh-phase-v-operating-rules)
- [CARIN Alliance (1)](https://blog.pocp.com/blog/tag/carin-alliance)
- [CDS Hooks (1)](https://blog.pocp.com/blog/tag/cds-hooks)
- [CMS Attachments Rule (1)](https://blog.pocp.com/blog/tag/cms-attachments-rule)
- [CRD (1)](https://blog.pocp.com/blog/tag/crd)
- [Canada Biosimilars Naming (1)](https://blog.pocp.com/blog/tag/canada-biosimilars-naming)
- [Canadian ePrescribing (1)](https://blog.pocp.com/blog/tag/canadian-eprescribing)
- [Chronic Disease (1)](https://blog.pocp.com/blog/tag/chronic-disease)
- [Clinical Quality Language (CQL) (1)](https://blog.pocp.com/blog/tag/clinical-quality-language-cql)
- [CodeX (1)](https://blog.pocp.com/blog/tag/codex)
- [CoverMyMeds (1)](https://blog.pocp.com/blog/tag/covermymeds)
- [DSMO (1)](https://blog.pocp.com/blog/tag/dsmo)
- [DTR (1)](https://blog.pocp.com/blog/tag/dtr)
- [DTx (1)](https://blog.pocp.com/blog/tag/dtx)
- [Data Modernization Initiative (1)](https://blog.pocp.com/blog/tag/data-modernization-initiative)
- [Data quality (1)](https://blog.pocp.com/blog/tag/data-quality)
- [Designated Standards Maintenance Organizations (1)](https://blog.pocp.com/blog/tag/designated-standards-maintenance-organizations)
- [Digital Therapeutics Opportunities (1)](https://blog.pocp.com/blog/tag/digital-therapeutics-opportunities)
- [Digital Therapeutics Outlook (1)](https://blog.pocp.com/blog/tag/digital-therapeutics-outlook)
- [Discover Alliance (1)](https://blog.pocp.com/blog/tag/discover-alliance)
- [Drug Launch (1)](https://blog.pocp.com/blog/tag/drug-launch)
- [Drug Manufacturers (1)](https://blog.pocp.com/blog/tag/drug-manufacturers)
- [Drug PA (1)](https://blog.pocp.com/blog/tag/drug-pa)
- [Drug abuse (1)](https://blog.pocp.com/blog/tag/drug-abuse)
- [EHR Apps (1)](https://blog.pocp.com/blog/tag/ehr-apps)
- [Enforcement (1)](https://blog.pocp.com/blog/tag/enforcement)
- [FQHC (1)](https://blog.pocp.com/blog/tag/fqhc)
- [Federally Qualified Health Centers (1)](https://blog.pocp.com/blog/tag/federally-qualified-health-centers)
- [Fee-for-service (1)](https://blog.pocp.com/blog/tag/fee-for-service)
- [Gold-carding (1)](https://blog.pocp.com/blog/tag/gold-carding)
- [HIN (1)](https://blog.pocp.com/blog/tag/hin)
- [HIPAA (1)](https://blog.pocp.com/blog/tag/hipaa)
- [HIT Leaders (1)](https://blog.pocp.com/blog/tag/hit-leaders)
- [HL7 Da Vinci Project (1)](https://blog.pocp.com/blog/tag/hl7-da-vinci-project)
- [HTI-4 (1)](https://blog.pocp.com/blog/tag/hti-4)
- [Health and Human Services (1)](https://blog.pocp.com/blog/tag/health-and-human-services)
- [Health data (1)](https://blog.pocp.com/blog/tag/health-data)
- [Health system (1)](https://blog.pocp.com/blog/tag/health-system)
- [Healthcare artificial intelligence trends (1)](https://blog.pocp.com/blog/tag/healthcare-artificial-intelligence-trends)
- [Human Services (1)](https://blog.pocp.com/blog/tag/human-services)
- [Hypertension (1)](https://blog.pocp.com/blog/tag/hypertension)
- [I-STOP (1)](https://blog.pocp.com/blog/tag/i-stop)
- [Insurance (1)](https://blog.pocp.com/blog/tag/insurance)
- [Landscape analysis (1)](https://blog.pocp.com/blog/tag/landscape-analysis)
- [MACRA (1)](https://blog.pocp.com/blog/tag/macra)
- [MIPS (1)](https://blog.pocp.com/blog/tag/mips)
- [Market Intelligence (1)](https://blog.pocp.com/blog/tag/market-intelligence)
- [Market Research (1)](https://blog.pocp.com/blog/tag/market-research)
- [Medication Therapy Management (1)](https://blog.pocp.com/blog/tag/medication-therapy-management)
- [Modernizing Part D CMS-4180-P (1)](https://blog.pocp.com/blog/tag/modernizing-part-d-cms-4180-p)
- [NCPDP F&B (1)](https://blog.pocp.com/blog/tag/ncpdp-fb)
- [NCPDP SCRIPT 2017071 (1)](https://blog.pocp.com/blog/tag/ncpdp-script-2017071)
- [NCPDP Workgroups (1)](https://blog.pocp.com/blog/tag/ncpdp-workgroups)
- [NCQA (1)](https://blog.pocp.com/blog/tag/ncqa)
- [NDC (1)](https://blog.pocp.com/blog/tag/ndc)
- [NPI (1)](https://blog.pocp.com/blog/tag/npi)
- [Objective Analysis (1)](https://blog.pocp.com/blog/tag/objective-analysis)
- [Outcomes (1)](https://blog.pocp.com/blog/tag/outcomes)
- [P2 FHIR Taskforce (1)](https://blog.pocp.com/blog/tag/p2-fhir-taskforce)
- [PAS (1)](https://blog.pocp.com/blog/tag/pas)
- [PBMs (1)](https://blog.pocp.com/blog/tag/pbms)
- [PIE (1)](https://blog.pocp.com/blog/tag/pie)
- [POCP News (1)](https://blog.pocp.com/blog/tag/pocp-news)
- [Pain Management (1)](https://blog.pocp.com/blog/tag/pain-management)
- [Payer to Payer (1)](https://blog.pocp.com/blog/tag/payer-to-payer)
- [Pharmacogenomics (1)](https://blog.pocp.com/blog/tag/pharmacogenomics)
- [Point-of-Care (1)](https://blog.pocp.com/blog/tag/point-of-care)
- [Prescribing Authority (1)](https://blog.pocp.com/blog/tag/prescribing-authority)
- [Prescribing signatures (1)](https://blog.pocp.com/blog/tag/prescribing-signatures)
- [Prescription Price Transparency (1)](https://blog.pocp.com/blog/tag/prescription-price-transparency)
- [Prescription affordability (1)](https://blog.pocp.com/blog/tag/prescription-affordability)
- [Prescription drug benefit (1)](https://blog.pocp.com/blog/tag/prescription-drug-benefit)
- [Prescription pricing (1)](https://blog.pocp.com/blog/tag/prescription-pricing)
- [Public Health (1)](https://blog.pocp.com/blog/tag/public-health)
- [Quality Measures (1)](https://blog.pocp.com/blog/tag/quality-measures)
- [RTBT (1)](https://blog.pocp.com/blog/tag/rtbt)
- [RTPB (1)](https://blog.pocp.com/blog/tag/rtpb)
- [Regulatory overhead (1)](https://blog.pocp.com/blog/tag/regulatory-overhead)
- [RelayHealth (1)](https://blog.pocp.com/blog/tag/relayhealth)
- [Retirement (1)](https://blog.pocp.com/blog/tag/retirement)
- [Rx renewal (1)](https://blog.pocp.com/blog/tag/rx-renewal)
- [RxBC (1)](https://blog.pocp.com/blog/tag/rxbc)
- [Sandbox (1)](https://blog.pocp.com/blog/tag/sandbox)
- [Social Determinants of Health (1)](https://blog.pocp.com/blog/tag/social-determinants-of-health)
- [Specialty Pharmacy Enrollment (1)](https://blog.pocp.com/blog/tag/specialty-pharmacy-enrollment)
- [Specialty medication (1)](https://blog.pocp.com/blog/tag/specialty-medication)
- [Stark Anti-Kickback Statute (1)](https://blog.pocp.com/blog/tag/stark-anti-kickback-statute)
- [Stark Law Reform (1)](https://blog.pocp.com/blog/tag/stark-law-reform)
- [Surescripts (1)](https://blog.pocp.com/blog/tag/surescripts)
- [Telecommunications (1)](https://blog.pocp.com/blog/tag/telecommunications)
- [Telehealth / Telemedicine (1)](https://blog.pocp.com/blog/tag/telehealth-telemedicine)
- [U.S. Senate Special Committee on Aging (1)](https://blog.pocp.com/blog/tag/u-s-senate-special-committee-on-aging)
- [Uncategorized (1)](https://blog.pocp.com/blog/tag/uncategorized)
- [Virtual Visits (1)](https://blog.pocp.com/blog/tag/virtual-visits)
- [Working from home (1)](https://blog.pocp.com/blog/tag/working-from-home)
- [X12 (1)](https://blog.pocp.com/blog/tag/x12)
- [ambient listening (1)](https://blog.pocp.com/blog/tag/ambient-listening)
- [blockchain (1)](https://blog.pocp.com/blog/tag/blockchain)
- [care access (1)](https://blog.pocp.com/blog/tag/care-access)
- [cms-0057 (1)](https://blog.pocp.com/blog/tag/cms-0057)
- [consumerism (1)](https://blog.pocp.com/blog/tag/consumerism)
- [data platforms (1)](https://blog.pocp.com/blog/tag/data-platforms)
- [digiceuticals (1)](https://blog.pocp.com/blog/tag/digiceuticals)
- [digital health platforms (1)](https://blog.pocp.com/blog/tag/digital-health-platforms)
- [eConsent (1)](https://blog.pocp.com/blog/tag/econsent)
- [eMedication Management (1)](https://blog.pocp.com/blog/tag/emedication-management)
- [healthcare (1)](https://blog.pocp.com/blog/tag/healthcare)
- [home health (1)](https://blog.pocp.com/blog/tag/home-health)
- [machine learning (1)](https://blog.pocp.com/blog/tag/machine-learning)
- [medical deserts (1)](https://blog.pocp.com/blog/tag/medical-deserts)
- [patient generated data (1)](https://blog.pocp.com/blog/tag/patient-generated-data)
- [payers (1)](https://blog.pocp.com/blog/tag/payers)
- [payment model (1)](https://blog.pocp.com/blog/tag/payment-model)
- [pharmacy-delivered clinical services (1)](https://blog.pocp.com/blog/tag/pharmacy-delivered-clinical-services)
- [prescription drug monitoring programs (1)](https://blog.pocp.com/blog/tag/prescription-drug-monitoring-programs)
- [rural health (1)](https://blog.pocp.com/blog/tag/rural-health)
- [scope of practice (1)](https://blog.pocp.com/blog/tag/scope-of-practice)
- [vive (1)](https://blog.pocp.com/blog/tag/vive)
See all
[](https://www.pocp.com)
©2026 Point-of-Care Partners | All Rights Reserved
- [](https://twitter.com/pocpHIT)
- [](http://www.linkedin.com/company/point-of-care-partners)
- [](https://www.pocp.com/pocp-blog/)
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"author" : {
"@type" : "Person",
"name" : "Brian Bamberger",
"url" : "https://blog.pocp.com/blog/author/brian-bamberger"
},
"dateModified" : "2025-04-01T19:32:23.484Z",
"datePublished" : "2025-04-01T19:32:23.000Z",
"headline" : "Pre-approval Information Exchange (PIE): Clarifying Legislation Creates Opportunities to Accelerate Product Launches",
"image" : [ "https://blog.pocp.com/hubfs/20250331_1012_Data%20Pie%20Icon_simple_compose_01jqp8r4kxejqvfx8wdvkr3may.png" ],
"mainEntityOfPage" : {
"@id" : "https://blog.pocp.com/blog/pre-approval-information-exchange-pie-clarifying-legislation-creates-opportunities-to-accelerate-product-launches",
"@type" : "WebPage"
},
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://blog.pocp.com/hubfs/pocp-logo-2016.jpg"
},
"name" : "Point-of-Care Partners"
}
}
```